BIEL. Hard to pass this one up. Increasing revenue's and about to announce official FDA approval for 1 of it's products that will lead to more. It's a sub penny now but I dont think it will be for long.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.